Variables (n=106 patients) | n (%) or median (IQR) |
Demographics | |
Age | 4 (2.0,12) |
Weight (kg) | 14.0 (7.0, 29.5) |
Height (cm) | 98.0 (71.5, 141.0) |
Sex: female | 54 (51) |
Physiologic diagnosis: no structural heart defects | 4 (3.8) |
Isolated defects | 68 (65) |
Pulmonary hypertension | 5 (4.2) |
Complex two-ventricle physiology | 17 (16) |
Single ventricle physiology | 12 (11) |
STS diagnosis: thoracic artery defects | |
PDA | 21 (20) |
CoA | 4 (3.8) |
Septal defects | |
ASD | 19 (18) |
VSD | 18 (17) |
CAVSD | 4 (3.8) |
dTGA | 12 (11.5) |
Single ventricle | 12 (11.5) |
Right-sided lesions | |
PS | 5 (4.5) |
Pulmonary atresia | 5 (4.5) |
Left-sided lesions | |
AS | 1 (1) |
Others | 5 (4.5) |
Defined or suspected genetic syndrome | 5 (5) |
Procedure t ype | |
Diagnostic | 45 (43) |
All interventional | 61 (58) |
Radiation | |
Fluoroscopy time (min) | 10.1 (7.1, 17.8) |
DAP (μGy) | 163.5 (85.9, 465.3) |
Air kerma (mGy) | 21.5 (11.4, 53.5) |
Adverse event | 10 (10) |
Categories | |
Sedation or airway related: apnoea | 1 (1) |
Catheterisation-related problem | |
Arrhythmias | 2 (2) |
Haemodynamics | 3 (3) |
Others | 1 (1) |
Access related: haematoma | 2 (2) |
Stent-related problem: thrombosis | 1 (1) |
Event | |
Preventability | |
Preventable | 4 (4) |
Possibly preventable | 4 (4) |
Not preventable | 2 (2) |
Seriousness | |
Level 1 | 1 (1) |
Level 2 | 3 (3) |
Level 3 | 4 (4) |
Level 4 | 2 (2) |
PDA, Patent ductus arteriosus; CoA, coarctation of aorta; ASD, Atrial septal defect; VSD, Ventricular septal defect; CAVSD, Complete atrioventricular septal defect; dTGA, d-Transposition of great arteries; PS, Pulmonary stenosis; AS, Aortic stenosis; DAP, Dose area product.